Senate: Accompanied a study order, see S2931
Email me when S 863 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 863. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill directs Massachusetts Medicaid managed‑care plans to treat FDA‑approved non‑opioid pain medications no less favorably than opioid drugs, and requires comprehensive, multidisciplinary chronic‑pain services for enrollees. It also creates a data‑collection mandate for a state center to track chronic‑pain incidence, costs, and outcomes. The goal is to improve pain management options while reducing reliance on opioids.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 863
3 free questions a day, no accountHearings
- Joint Committee on Health Care Financing Hearing on Single-Payer Bills and Miscellaneous MattersJoint Committee on Health Care Financing · Jun 18, 2025
History
- Accompanied a study order, see S2931
- Hearing scheduled for 06/18/2025 from 11:00 AM-03:00 PM in Gardner Auditorium
- Referred to the committee on Health Care Financing
- House concurred
Sponsors
- Dylan A. Fernandes · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 863 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 863 freeOr ask your AI assistant about S 863 directly:
Add to Claude, ChatGPT or Cursor